Noble Life Sciences, Inc. — Form D
Noble Life Sciences, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2012-04-10. The offering totals $235K, of which $235K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-04-10
- Form: D
- Accession: 0001546887-12-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $235K
- Amount sold: $235K
- Investors: 5
- Date of first sale: 2010-12-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-176430
Issuer
- Name: Noble Life Sciences, Inc.
- CIK: 0001546887
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 22 FIRSTFIELD ROAD, GAITHERSBURG, MD, 20878
- Phone: 301-861-0009
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Kenneth Carter | Director | SAN FRANCISCO, CA |
| Alain Cappeluti | Executive Officer | Gaithersburg, MD |
| Kenneth Carter | Executive Officer | SAN FRANCISCO, CA |
More